IMO, market is excited about this:
https://*.com.au/news/find-out-more-about-the-new-cancer-therapy-thats-set-to-break-the-glass-ceiling-in-australian-cancer-treatment/
Just last week, the oncology company announced it had commenced a phase 1b trial of PTX-100 and that it had enrolled patients with multiple cancer types. The first dosed patient was a multiple myeloma patient, who successfully completed a week of therapy with PTX-100 without any notable drug-related side effects.
Story about actor Tom Long, now cancer free, in the media.
